Recent advances in paediatric respiratory medicine.
This review highlights important advances in paediatric respiratory medicine since 2014, excluding cystic fibrosis. It focuses mainly on the more common conditions, bronchopulmonary dysplasia, bronchiolitis and preschool wheezing, asthma, pneumonia and sleep, and highlights some of the rarer conditions such as primary ciliary dyskinesia and interstitial lung disease (ILD).
Department of Paediatric Respiratory Medicine, Royal Brompton Hospital, London, UK.
Andrew
A
Turnbull
Department of Paediatric Respiratory Medicine, Royal Brompton Hospital, London, UK.
Ian M
IM
Balfour-Lynn
D000085:Acetates / Q000627:therapeutic use; D018927:Anti-Asthmatic Agents / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy / Q000401:mortality; D001997:Bronchopulmonary Dysplasia / Q000150:complications / Q000628:therapy; D002925:Ciliary Motility Disorders / Q000175:diagnosis; D003521:Cyclopropanes; D006801:Humans; D017563:Lung Diseases, Interstitial / Q000175:diagnosis / Q000628:therapy; D055118:Medication Adherence; D010372:Pediatrics / Q000639:trends*; D015272:Pulmonary Medicine / Q000639:trends*; D011804:Quinolines / Q000627:therapeutic use; D012462:Saline Solution, Hypertonic / Q000627:therapeutic use; D020181:Sleep Apnea, Obstructive / Q000601:surgery; D013440:Sulfides
D000085:Acetates; D018927:Anti-Asthmatic Agents; D003521:Cyclopropanes; D011804:Quinolines; D012462:Saline Solution, Hypertonic; D013440:Sulfides; C093875:montelukast
Paediatric Practice; Respiratory